Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Sci Prog ; 104(2): 368504211012159, 2021.
Article in English | MEDLINE | ID: mdl-33926312

ABSTRACT

A wide variety of methods have synthesized silver nanoparticles (Ag-NPs) in the recent past; however, biological methods have attracted much attention over the traditional chemical synthesis method due to being non-hazardous and eco-friendly. Here, a detailed and systemic study was performed to compare two different synthesis routes for Ag-NPs, that is, the chemical and the biological; their possible outcomes have also been described. Ag-NPs were synthesized chemically (cAg-NPs) using a chemical reductant and biologically (bAg-NPs) by using aqueous leaf extract of Azadirachta indica (neem). The synthesized nanoparticles were characterized using UV-visible spectrophotometry, FT-IR, EDX, and TEM. The average particle sizes (APS) of cAg-NPs were found to be 8 and 13 nm and of bAg-NPs to be 19 and 43 nm under different AgNO3 concentrations. The antimicrobial tests of differently sized NPs were performed against Escherichia coli (Gram -ve) and Staphylococcus aureus (Gram +ve). The results revealed that bAg-NPs of APS 43 nm were highly antimicrobial against both the tested bacterial stains followed by cAg-NPs of 8 nm. We found the effect of cAg-NPs to be size-dependent, whereas bAg-NPs showed a more significant antimicrobial effect than cAg-NPs.


Subject(s)
Anti-Infective Agents , Azadirachta , Metal Nanoparticles , Anti-Bacterial Agents/pharmacology , Anti-Infective Agents/pharmacology , Azadirachta/chemistry , Escherichia coli , Metal Nanoparticles/chemistry , Plant Extracts/pharmacology , Silver/chemistry , Silver/pharmacology , Spectroscopy, Fourier Transform Infrared
2.
Curr Pharm Biotechnol ; 22(15): 2019-2030, 2021.
Article in English | MEDLINE | ID: mdl-33463460

ABSTRACT

AIMS: Globally, scientists are working to find more efficient antimicrobial drugs to treat microbial infections and kill drug-resistant bacteria. BACKGROUND: Despite the availability of numerous antimicrobial drugs, bacterial infections still pose a serious threat to global health. A constant decline in the effectiveness of antibiotics owing to their repeated exposure as well as a short-lasting antimicrobial activity led to the demand for developing novel therapeutic agents capable of controlling microbial infections. OBJECTIVE: In this study, we report the antimicrobial activity of chemically synthesized silver nanoparticles (cAgNPs) augmented with ampicillin (amp) in order to increase antimicrobial response against Escherichia coli (gram -ve), Staphylococcus aureus (gram +ve) and Streptococcus mutans (gram +ve). METHODS: Nanostructure, colloidal stability, morphology and size of cAgNPs before and after functionalization were explored by UV-vis spectroscopy, FT-IR, zeta potential and TEM. The formation and functionalization of cAgNPs were confirmed from UV-vis spectroscopy and FT-IR patterns. From TEM, the average sizes of cAgNPs and cAgNP-amp were found to be 13 and 7.8 nm, respectively, and change in colloidal stability after augmentation was confirmed from zeta potential values. The antimicrobial efficacies of cAgNP-amp and cAgNPs against E. coli S. aureus and S. mutans were studied by determining Minimum Inhibitory Concentrations (MICs), zone of inhibition, assessment of viable and non-viable bacterial cells and quantitative assessment of biofilm. RESULTS & DISCUSSION: Our results revealed cAgNP-amp to be highly bactericidal compared to cAgNPs or amp alone. The nano-toxicity studies indicated cAgNP-amp to be less toxic compared to cAgNPs alone. CONCLUSION: This study manifested that cAgNPs show synergistic antimicrobial effects when they get functionalized with amp suggesting their application in curing long-term bacterial infections.


Subject(s)
Anti-Infective Agents , Metal Nanoparticles , Ampicillin/pharmacology , Anti-Bacterial Agents/pharmacology , Escherichia coli , Microbial Sensitivity Tests , Silver , Spectroscopy, Fourier Transform Infrared , Staphylococcus aureus
SELECTION OF CITATIONS
SEARCH DETAIL